|
|
cellular phosphate ion homeostasis
|
GO:0030643 |
2 |
1.000
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.996
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.990
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.989
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.988
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.987
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.987
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.985
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.985
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.980
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.978
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.975
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.975
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.973
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.972
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.971
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.969
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.969
|
|
|
|
positive regulation of heart rate by epinephrine norepinephrine
|
GO:0001996 |
4 |
0.969
|
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.968
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.966
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.965
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.964
|
|
|
|
vasodilation by norepinephrine epinephrine involved in regulation of systemic arterial blood pressure
|
GO:0002025 |
3 |
0.964
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.964
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.962
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.962
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.956
|
|
|
|
regulation of steroid biosynthetic process
|
GO:0050810 |
26 |
0.956
|
|
|
|
inorganic anion transport
|
GO:0015698 |
43 |
0.956
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.954
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.953
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.953
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.953
|
|
|
|
histamine induced gastric acid secretion
|
GO:0001697 |
1 |
0.952
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.950
|
|
|
|
positive regulation of camp metabolic process
|
GO:0030816 |
19 |
0.945
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.945
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.944
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.943
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.938
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.937
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.936
|
|
|
|
g protein coupled receptor internalization
|
GO:0002031 |
3 |
0.935
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.932
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.932
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.930
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.925
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.924
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.924
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.924
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.922
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.921
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.920
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.917
|
|
|
|
positive regulation of the force of heart contraction by epinephrine norepinephrine
|
GO:0001997 |
3 |
0.915
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.914
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.903
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.900
|
|
|
|
regulation of systemic arterial blood pressure by norepinephrine epinephrine
|
GO:0001993 |
8 |
0.899
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.899
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.898
|
|
|
|
temperature homeostasis
|
GO:0001659 |
26 |
0.895
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.893
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.893
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.892
|
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.892
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.892
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.891
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.891
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.890
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.889
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.888
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.887
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.886
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.885
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.881
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.880
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.880
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.878
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.878
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
26 |
0.877
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.876
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.875
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.874
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.871
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.870
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.869
|
|
|
|
regulation of camp biosynthetic process
|
GO:0030817 |
25 |
0.867
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.860
|
|
|
|
hormone biosynthetic process
|
GO:0042446 |
16 |
0.859
|
|
|
|
cellular divalent inorganic anion homeostasis
|
GO:0072501 |
3 |
0.859
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.856
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.856
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.855
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.855
|
|
|
|
positive regulation of lyase activity
|
GO:0051349 |
11 |
0.854
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.851
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.851
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.850
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.848
|
|
|
|
forebrain neuron development
|
GO:0021884 |
30 |
0.848
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.843
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.843
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.839
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.839
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.836
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.833
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.830
|
|
|
|
phospholipase c activating serotonin receptor signaling pathway
|
GO:0007208 |
1 |
0.825
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.823
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.822
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.820
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.816
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.815
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.814
|
|
|
|
regulation of cyclic nucleotide biosynthetic process
|
GO:0030802 |
31 |
0.814
|
|
|
|
camp mediated signaling
|
GO:0019933 |
15 |
0.811
|
|
|
|
positive regulation of atpase activity
|
GO:0032781 |
3 |
0.811
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.809
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.807
|
|
|
|
homotypic cell cell adhesion
|
GO:0034109 |
28 |
0.805
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.803
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.801
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.800
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.798
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.798
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
30 |
0.797
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.797
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.796
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.791
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.787
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.786
|
|
|
|
biological phase
|
GO:0044848 |
20 |
0.785
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.783
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.783
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.780
|
|
|
|
negative regulation of muscle contraction
|
GO:0045932 |
12 |
0.776
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.775
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.774
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.771
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.771
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
24 |
0.768
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.756
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.753
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.751
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.747
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.744
|
|
|
|
regulation of adenylate cyclase activity
|
GO:0045761 |
10 |
0.743
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.743
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.743
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.742
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.741
|
|
|
|
gastrin induced gastric acid secretion
|
GO:0001698 |
1 |
0.739
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.737
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.737
|
|
|
|
response to amine
|
GO:0014075 |
16 |
0.736
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.732
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.728
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.727
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.727
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.723
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.721
|
|
|
|
regulation of serotonin secretion
|
GO:0014062 |
3 |
0.712
|
|
|
|
response to vitamin d
|
GO:0033280 |
3 |
0.708
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.708
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.707
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.707
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.707
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.707
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.704
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.698
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.697
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.696
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.696
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.695
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.694
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.693
|
|
|
|
positive regulation of cyclic nucleotide metabolic process
|
GO:0030801 |
24 |
0.692
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.690
|
|
|
|
negative regulation of serotonin secretion
|
GO:0014063 |
2 |
0.690
|
|
|
|
rhodopsin mediated signaling pathway
|
GO:0016056 |
4 |
0.685
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.683
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.683
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.682
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.680
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.679
|
|
|
|
regulation of bone mineralization
|
GO:0030500 |
31 |
0.678
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.677
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.676
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.675
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.673
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.672
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.670
|
|
|
|
acid secretion
|
GO:0046717 |
33 |
0.668
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.665
|
|
|
|
negative regulation of systemic arterial blood pressure
|
GO:0003085 |
15 |
0.664
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.664
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.663
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
31 |
0.662
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.661
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.661
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.660
|
|
|
|
positive regulation of blood pressure by epinephrine norepinephrine
|
GO:0003321 |
6 |
0.654
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.651
|
|
|
|
regulation of corticotropin releasing hormone secretion
|
GO:0043397 |
2 |
0.649
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.645
|
|
|
|
energy reserve metabolic process
|
GO:0006112 |
39 |
0.644
|
|
|
|
memory
|
GO:0007613 |
58 |
0.644
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.643
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.642
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.642
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.637
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.633
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.633
|
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.633
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.632
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.631
|
|
|
|
mammary gland branching involved in pregnancy
|
GO:0060745 |
6 |
0.627
|
|
|
|
sensitization
|
GO:0046960 |
2 |
0.625
|
|
|
|
positive regulation of glycolytic process
|
GO:0045821 |
4 |
0.623
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.623
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.621
|
|
|
|
serotonin receptor signaling pathway
|
GO:0007210 |
8 |
0.620
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.618
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.616
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.613
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.612
|
|
|
|
positive regulation of camp biosynthetic process
|
GO:0030819 |
19 |
0.605
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.605
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.601
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.600
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.599
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.593
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.589
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.584
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.584
|
|
|
|
long term synaptic potentiation
|
GO:0060291 |
25 |
0.582
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.581
|
|
|
|
cyclic nucleotide mediated signaling
|
GO:0019935 |
18 |
0.581
|
|
|
|
sensory perception of taste
|
GO:0050909 |
18 |
0.580
|
|
|
|
regulation of lyase activity
|
GO:0051339 |
13 |
0.579
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.578
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.577
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.575
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.574
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.573
|
|
|
|
response to parathyroid hormone
|
GO:0071107 |
3 |
0.572
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.565
|
|
|
|
positive regulation of insulin secretion
|
GO:0032024 |
26 |
0.565
|
|
|
|
glucose import
|
GO:0046323 |
32 |
0.562
|
|
|
|
negative regulation of blood pressure
|
GO:0045776 |
22 |
0.560
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.560
|
|
|
|
phospholipase c activating dopamine receptor signaling pathway
|
GO:0060158 |
5 |
0.559
|
|
|
|
establishment of anatomical structure orientation
|
GO:0048560 |
1 |
0.557
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.553
|
|
|
|
habituation
|
GO:0046959 |
3 |
0.550
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.544
|
|
|
|
platelet aggregation
|
GO:0070527 |
20 |
0.543
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.540
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.537
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.531
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.529
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
34 |
0.528
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.522
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.519
|
|
|
|
regulation of appetite
|
GO:0032098 |
12 |
0.516
|
|
|
|
adrenergic receptor signaling pathway
|
GO:0071875 |
13 |
0.516
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.515
|
|
|
|
regulation of atp metabolic process
|
GO:1903578 |
17 |
0.514
|
|
|
|
catecholamine metabolic process
|
GO:0006584 |
30 |
0.513
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.509
|
|
|
|
negative regulation of hormone biosynthetic process
|
GO:0032353 |
4 |
0.506
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.500
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.497
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.492
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.489
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.483
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.483
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.483
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.482
|
|
|
|
regulation of the force of heart contraction
|
GO:0002026 |
17 |
0.481
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.480
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.479
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.479
|
|
|
|
positive regulation of the force of heart contraction by chemical signal
|
GO:0003099 |
3 |
0.479
|
|
|
|
positive regulation of blood pressure
|
GO:0045777 |
21 |
0.478
|
|
|
|
positive regulation of biomineral tissue development
|
GO:0070169 |
12 |
0.476
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.473
|
|
|
|
desensitization of g protein coupled receptor protein signaling pathway
|
GO:0002029 |
5 |
0.473
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.469
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.469
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.468
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.468
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.466
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.465
|
|
|
|
regulation of synaptic transmission glutamatergic
|
GO:0051966 |
19 |
0.461
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.458
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.457
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.449
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.448
|
|
|
|
response to cocaine
|
GO:0042220 |
14 |
0.447
|
|
|
|
associative learning
|
GO:0008306 |
61 |
0.447
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.446
|
|
|
|
adenylate cyclase activating dopamine receptor signaling pathway
|
GO:0007191 |
7 |
0.445
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.440
|
|
|
|
response to estrogen
|
GO:0043627 |
24 |
0.439
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.437
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.436
|
|
|
|
androgen metabolic process
|
GO:0008209 |
11 |
0.436
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.435
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.433
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.433
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.433
|
|
|
|
response to alkaloid
|
GO:0043279 |
34 |
0.432
|
|
|
|
dopamine metabolic process
|
GO:0042417 |
23 |
0.431
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.429
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.429
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.427
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.426
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.425
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.425
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.423
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.421
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.420
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.419
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.414
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.414
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.413
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.413
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.413
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.412
|
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
41 |
0.412
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.412
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.411
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.408
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.408
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.404
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.403
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.403
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.401
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.400
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.399
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.397
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.395
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.395
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.394
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.386
|
|
|
|
visual behavior
|
GO:0007632 |
45 |
0.386
|
|
|
|
astrocyte development
|
GO:0014002 |
12 |
0.385
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.382
|
|
|
|
positive regulation of adenylate cyclase activity
|
GO:0045762 |
8 |
0.381
|
|
|
|
positive regulation of synaptic transmission glutamatergic
|
GO:0051968 |
8 |
0.380
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.380
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.378
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.378
|
|
|
|
serotonin transport
|
GO:0006837 |
11 |
0.376
|
|
|
|
negative regulation of steroid metabolic process
|
GO:0045939 |
8 |
0.374
|
|
|
|
regulation of cyclase activity
|
GO:0031279 |
13 |
0.371
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.370
|
|
|
|
peptidyl threonine modification
|
GO:0018210 |
31 |
0.370
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.367
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.367
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.367
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.367
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.365
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.365
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.364
|
|
|
|
neural crest cell migration
|
GO:0001755 |
32 |
0.361
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.361
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.358
|
|
|
|
toxin transport
|
GO:1901998 |
38 |
0.356
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.355
|
|
|
|
cerebral cortex gabaergic interneuron migration
|
GO:0021853 |
6 |
0.354
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.354
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.350
|
|
|
|
lateral sprouting involved in mammary gland duct morphogenesis
|
GO:0060599 |
2 |
0.347
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.343
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.343
|
|
|
|
mammary gland lobule development
|
GO:0061377 |
22 |
0.343
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.339
|
|
|
|
positive regulation of cellular carbohydrate metabolic process
|
GO:0010676 |
29 |
0.338
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.337
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.335
|
|
|
|
response to testosterone
|
GO:0033574 |
3 |
0.333
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.331
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.331
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
33 |
0.331
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.331
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.330
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.330
|
|
|
|
wnt signaling pathway calcium modulating pathway
|
GO:0007223 |
2 |
0.329
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
3 |
0.324
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.324
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.323
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.323
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.322
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.321
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.320
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.317
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.317
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.317
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.316
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.315
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.314
|
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
22 |
0.314
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.314
|
|
|
|
operant conditioning
|
GO:0035106 |
2 |
0.312
|
|
|
|
regulation of the force of heart contraction by chemical signal
|
GO:0003057 |
5 |
0.311
|
|
|
|
positive regulation of carbohydrate metabolic process
|
GO:0045913 |
30 |
0.310
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.310
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.309
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.308
|
|
|
|
multicellular organismal metabolic process
|
GO:0044236 |
28 |
0.308
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.307
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.306
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.306
|
|
|
|
adenylate cyclase inhibiting g protein coupled receptor signaling pathway
|
GO:0007193 |
20 |
0.304
|
|
|
|
negative regulation of nucleotide metabolic process
|
GO:0045980 |
16 |
0.304
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.303
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.303
|
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.303
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.302
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.300
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.297
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.297
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.297
|
|
|
|
carnitine transmembrane transport
|
GO:1902603 |
3 |
0.297
|
|
|
|
regulation of branching involved in ureteric bud morphogenesis
|
GO:0090189 |
22 |
0.295
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.295
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.295
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.294
|
|
|
|
positive regulation of bone mineralization
|
GO:0030501 |
12 |
0.294
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.294
|
|
|
|
phasic smooth muscle contraction
|
GO:0014821 |
8 |
0.293
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.293
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.292
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.292
|
|
|
|
negative regulation of steroid biosynthetic process
|
GO:0010894 |
8 |
0.291
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.289
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.289
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.286
|
|
|
|
positive regulation of cell division
|
GO:0051781 |
31 |
0.286
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.286
|
|
|
|
synaptic transmission glutamatergic
|
GO:0035249 |
36 |
0.285
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.285
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.284
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.282
|
|
|
|
bile acid metabolic process
|
GO:0008206 |
17 |
0.282
|
|
|
|
hair cycle phase
|
GO:0044851 |
16 |
0.279
|
|
|
|
neuropeptide signaling pathway
|
GO:0007218 |
19 |
0.278
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.277
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.276
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.274
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.274
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.273
|
|
|
|
cellular response to vitamin d
|
GO:0071305 |
2 |
0.272
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.272
|
|
|
|
negative regulation of axon guidance
|
GO:1902668 |
8 |
0.271
|
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.268
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.268
|
|
|
|
positive regulation of heart rate
|
GO:0010460 |
10 |
0.267
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.267
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.265
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.264
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.262
|
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.261
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.261
|
|
|
|
peristalsis
|
GO:0030432 |
8 |
0.261
|
|
|
|
cerebral cortex gabaergic interneuron differentiation
|
GO:0021892 |
9 |
0.261
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.261
|
|
|
|
visual learning
|
GO:0008542 |
44 |
0.260
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.259
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.258
|
|
|
|
negative regulation of hormone metabolic process
|
GO:0032351 |
4 |
0.258
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.257
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.257
|
|
|
|
detection of chemical stimulus involved in sensory perception of pain
|
GO:0050968 |
3 |
0.255
|
|
|
|
positive regulation of branching involved in lung morphogenesis
|
GO:0061047 |
4 |
0.255
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.255
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.253
|
|
|
|
foregut regionalization
|
GO:0060423 |
3 |
0.252
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.251
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.251
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.249
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.249
|
|
